Skip to main content
. 2020 Dec 28;77(2):383–392. doi: 10.1161/HYPERTENSIONAHA.120.16547

Figure 6.

Figure 6.

Forest plot of randomized controlled trial estimates for risk of major adverse cardiovascular events in patients with existing cardiovascular disease receiving urate-lowering therapy or placebo/no treatment. I2 heterogeneity statistic: 0%. A random-effects meta-analysis model was used.